⌘K

Login Start Free

Home/Filings/4/0001562180-18-001429

4//SEC Filing

Shea Richard P 4

Accession 0001562180-18-001429

CIK 0001395937other

View on SEC.gov Company Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:04 PM ET

Size

5.5 KB

Accession

0001562180-18-001429

Insider Transaction Report

Form 4

Period: 2018-03-01

Syndax Pharmaceuticals IncSNDX

Director

Transactions

Award
Stock Option (Right to Buy)
2018-03-01+48,000→ 48,000 total
Exercise: $9.40Exp: 2028-03-01→ Common Stock (48,000 underlying)

Footnotes (1)

[F1]The stock option will vest in 48 successive equal monthly installments measured from February 8, 2018.

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

Syndax Pharmaceuticals Inc

CIK 0001395937

Entity typeother

Related Parties

1

filerCIK 0001294354

Filing Metadata

Form type: 4
Filed: Mar 4, 7:00 PM ET
Accepted: Mar 5, 4:04 PM ET
Size: 5.5 KB

View on SEC.gov